About us

Leukaemia Care is the UK’s leading leukaemia charity. For over 50 years, we have been dedicated to ensuring that everyone affected receives the best possible diagnosis, information, advice, treatment and support.

Who We Are and What We Do

Leukaemia Care is the UK’s leading leukaemia charity.

Our Strategic Plan

We exist to improve the lives of everyone affected by leukaemia, MDS and MPN. Over the last 50 years, we have come a long way, but there is more to be done.

Our Trustee Board

Here at Leukaemia Care we have a small but dedicated trustee board. Find out more about each member below.

Meet our Patrons and Ambassadors

Our Patrons help to raise awareness of our charity, blood cancers and issues facing patients and their families. We are grateful to them all for their wonderful support.

Vacancies

Find out more about the latest vacancies at Leukaemia Care.

Volunteering opportunities

Help us to improve the lives of everyone affected by leukaemia by volunteering your time and experience. Learn more about the latest volunteering opportunities at Leukaemia Care.

Privacy policy

The Leukaemia Care privacy policy as of 24th May 2018

Our cookie policy

Learn more about the types of cookies we use on our website.

Contact Us

For all general enquiries, information about events, fundraising or anything else, including requests for resources get in touch with us today using any of the details below.

Press and media centre

Looking to write an article about Leukaemia? We've got some of the facts and statistics that you can quote.

Annual Accounts and Reports

View our annual report and financial statements for the year ended in December 2020.

Fundraising Promise

Supporters drive everything we do at Leukaemia Care. It’s thanks to your generosity that we are able to support so many leukaemia patients, read on to learn more about our fundraising promise.

Our Complaints Procedure

Read more about our complaints procedure below.

Myeloproliferative neoplasms (MPN)

Myeloproliferative neoplasms, also known as myeloproliferative disorders (MPDs) are a group of conditions that are closely related to leukaemia.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

June 30th

5 things you need know about today’s new drug approval for CML patients

We are pleased to announce a new treatment, asciminib, has been approved for NHS use in chronic myeloid leukaemia (CML) patients after 2 or more tyrosine kinase inhibitors (TKIs)....

June 30th

Leukaemia Care successfully campaigns for new leukaemia treatment on behalf of CML patients

Leukaemia Care successfully campaigns for the National Institute for Health and Care Excellence (NICE) to approve asciminib on the NHS in England for chronic myeloid leukaemia (CML) patients after 2 or more tyrosine kinase inhibitors (TKIs). ...

June 23rd

5 reasons why you should attend our hybrid community gathering

Join our biggest community gathering virtually or in-person on Saturday 13th August 2022....